BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miele M, Busà R, Russelli G, Sorrentino MC, Di Bella M, Timoneri F, Mularoni A, Panarello G, Vitulo P, Conaldi PG, Bulati M. Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients. Am J Transplant 2021;21:2919-21. [PMID: 34058052 DOI: 10.1111/ajt.16702] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Killian JT, Houp JA, Burkholder GA, Roman Soto SA, Killian AC, Ong SC, Erdmann NB, Goepfert PA, Hauptfeld-dolejsek V, Leal SM, Zumaquero E, Nellore A, Agarwal G, Kew CE, Orandi BJ, Locke JE, Porrett PM, Levitan EB, Kumar V, Lund FE. COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19. Transpl Int 2022;35:10626. [DOI: 10.3389/ti.2022.10626] [Reference Citation Analysis]
2 Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ. Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. Open Forum Infect Dis 2021;8:ofab393. [PMID: 34395717 DOI: 10.1093/ofid/ofab393] [Reference Citation Analysis]
3 Guarino M, Cossiga V, Esposito I, Alessandro F, Morisco F. Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: the debate is open! J Hepatol 2021:S0168-8278(21)01961-9. [PMID: 34358567 DOI: 10.1016/j.jhep.2021.07.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
4 Charmetant X, Espi M, Benotmane I, Barateau V, Heibel F, Buron F, Gautier-Vargas G, Delafosse M, Perrin P, Koenig A, Cognard N, Levi C, Gallais F, Manière L, Rossolillo P, Soulier E, Pierre F, Ovize A, Morelon E, Defrance T, Fafi-Kremer S, Caillard S, Thaunat O. Infection or a third dose of mRNA vaccine elicit neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients. Sci Transl Med 2022;:eabl6141. [PMID: 35103481 DOI: 10.1126/scitranslmed.abl6141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
5 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
6 Jatoi HN, Abbas S, Abbasi MS, Tauni MA, Ghazanfar S, Zafar Malick MD, Umar MF, Tahir MJ, Asghar MS, Ahmed A. BNT162b2 vaccine considerations for immunocompromised individuals: A global perspective. Ann Med Surg (Lond) 2022;78:103796. [PMID: 35603097 DOI: 10.1016/j.amsu.2022.103796] [Reference Citation Analysis]
7 Marra AR, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto BM, Bariani LM, Auler MA, Salinas JL, Edmond MB, Doll M, Kutner JM, Pinho JRR, Rizzo LV, Miraglia JL, Schweizer ML. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis. J Infect 2022:S0163-4453(21)00658-7. [PMID: 34982962 DOI: 10.1016/j.jinf.2021.12.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
8 Stock PG, Henrich TJ, Segev DL, Werbel WA. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest 2021;131:151178. [PMID: 34143755 DOI: 10.1172/JCI151178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 28.0] [Reference Citation Analysis]
10 Deng X, Evdokimova M, O'Brien A, Rowe CL, Clark NM, Harrington A, Reid GE, Uprichard SL, Baker SC. Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients. Viruses 2021;13:1743. [PMID: 34578324 DOI: 10.3390/v13091743] [Reference Citation Analysis]
11 Lindemann M, Klisanin V, Thümmler L, Fisenkci N, Tsachakis-Mück N, Ditschkowski M, Schwarzkopf S, Klump H, Reinhardt HC, Horn PA, Koldehoff M. Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients. Vaccines (Basel) 2021;9:1075. [PMID: 34696183 DOI: 10.3390/vaccines9101075] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Miele M, Busà R, Russelli G, Sorrentino MC, Di Bella M, Timoneri F, Vitale G, Calzolari E, Vitulo P, Mularoni A, Conaldi PG, Bulati M. Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection. Microorganisms 2022;10:1563. [DOI: 10.3390/microorganisms10081563] [Reference Citation Analysis]
13 Westhoff TH, Seibert FS, Anft M, Blazquez-Navarro A, Skrzypczyk S, Zgoura P, Meister TL, Pfaender S, Stumpf J, Hugo C, Viebahn R, Roch T, Stervbo U, Babel N. A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse. Kidney Int 2021;100:1135-6. [PMID: 34509489 DOI: 10.1016/j.kint.2021.09.001] [Reference Citation Analysis]
14 Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00566-8. [PMID: 35020589 DOI: 10.1016/j.cmi.2021.09.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 24.0] [Reference Citation Analysis]
15 Hamm SR, Møller DL, Pérez-Alós L, Hansen CB, Pries-Heje MM, Heftdal LD, Hasselbalch RB, Fogh K, Madsen JR, Almagro Armenteros JJ, Knudsen AD, Poulsen JR, Frikke-Schmidt R, Hilsted LM, Sørensen E, Ostrowski SR, Harboe ZB, Perch M, Sørensen SS, Rasmussen A, Bundgaard H, Garred P, Iversen K, Nielsen SD. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls. Front Immunol 2022;13:832501. [PMID: 35281023 DOI: 10.3389/fimmu.2022.832501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sutharattanapong N, Thotsiri S, Kantachuvesiri S, Wiwattanathum P. Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients. Vaccines 2022;10:572. [DOI: 10.3390/vaccines10040572] [Reference Citation Analysis]
17 Kute V, Meshram HS, Sharma A, Chaudhury AR, Sudhindran S, Gokhale AK, Hote M, Guleria R, Rana DS, Prakash J, Ramesh V. Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients. Transplant Proc 2021:S0041-1345(21)00683-7. [PMID: 34690000 DOI: 10.1016/j.transproceed.2021.09.007] [Reference Citation Analysis]
18 Yanis A, Haddadin Z, Spieker AJ, Waqfi D, Rankin DA, Talj R, Thomas L, Birdwell KA, Ezzell L, Blair M, Eason J, Varjabedian R, Warren CM, Nochowicz CH, Olson EC, Simmons JD, Yoder S, Guy M, Thomsen I, Chappell JD, Kalams SA, Halasa NB. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls. Transpl Infect Dis 2021;:e13772. [PMID: 34905653 DOI: 10.1111/tid.13772] [Reference Citation Analysis]
19 Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res 2021:S1931-5244(21)00269-3. [PMID: 34780969 DOI: 10.1016/j.trsl.2021.11.006] [Reference Citation Analysis]
20 Bachelet T, Bourdenx JP, Martinez C, Mucha S, Martin-Dupont P, Perier V, Pommereau A. Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times. PLoS One 2021;16:e0257646. [PMID: 34610031 DOI: 10.1371/journal.pone.0257646] [Reference Citation Analysis]
21 Sadeghalvad M, Mansourabadi AH, Noori M, Nejadghaderi SA, Masoomikarimi M, Alimohammadi M, Rezaei N. Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies. Reviews in Medical Virology. [DOI: 10.1002/rmv.2359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cassaniti I, Bergami F, Arena F, Sammartino JC, Ferrari A, Zavaglio F, Curti I, Percivalle E, Meloni F, Pandolfi L, Pellegrini C, Turco A, Seminari E, Pattonieri EF, Gregorini M, Rampino T, Sarasini A, Lilleri D, Baldanti F. Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant. Microorganisms 2021;9:2622. [PMID: 34946223 DOI: 10.3390/microorganisms9122622] [Reference Citation Analysis]
23 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]
24 D'Offizi G, Agrati C, Visco-Comandini U, Castilletti C, Puro V, Piccolo P, Montalbano M, Meschi S, Tartaglia E, Sorace C, Leone S, Lapa D, Grassi G, Goletti D, Ippolito G, Vaia F, Ettorre GM, Lionetti R. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients. Liver Int 2021. [PMID: 34719107 DOI: 10.1111/liv.15089] [Reference Citation Analysis]
25 Bothou C, Saleh L, von Eckardstein A, Beuschlein F, Nowak A. COVID-19 in Fabry disease: a reference center prospective study. Orphanet J Rare Dis 2022;17:250. [PMID: 35765080 DOI: 10.1186/s13023-022-02386-7] [Reference Citation Analysis]
26 Al Jurdi A, Gassen RB, Borges TJ, Solhjou Z, Hullekes FE, Lape IT, Efe O, Alghamdi A, Patel P, Choi JY, Mohammed MT, Bohan B, Pattanayak V, Rosales I, Cravedi P, Kotton CN, Azzi JR, Riella LV. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination. Front Immunol 2022;13:838985. [PMID: 35281011 DOI: 10.3389/fimmu.2022.838985] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
27 Loconsole D, Stea ED, Sallustio A, Fontò G, Pronzo V, Simone S, Centrone F, Accogli M, Gesualdo L, Chironna M. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients. Vaccines (Basel) 2021;9:806. [PMID: 34451931 DOI: 10.3390/vaccines9080806] [Reference Citation Analysis]
28 Kamp JC, Hinrichs JB, Fuge J, Ewen R, Gottlieb J. COVID-19 in lung transplant recipients-Risk prediction and outcomes. PLoS One 2021;16:e0257807. [PMID: 34613977 DOI: 10.1371/journal.pone.0257807] [Reference Citation Analysis]
29 Downes KJ, Statler VA, Orscheln RC, Cousino MK, Green M, Michaels MG, Muller WJ, Sharma TS, Danziger-Isakov LA, Ardura MI. Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022. J Pediatric Infect Dis Soc 2021:piab098. [PMID: 34734268 DOI: 10.1093/jpids/piab098] [Reference Citation Analysis]